Changes in craniofacial development induced by growth hormone therapy in children treated with bone marrow transplantation.
The effect of growth hormone (GH) treatment on craniofacial development was studied in nine children exhibiting low growth velocity after bone marrow transplantation (BMT). Comparisons were made with seven BMT children who had not received GH. Two groups of age- and sex-matched healthy children served as controls for the respective patient groups. After an average observation period of 3.5 years, the BMT children not treated with GH exhibited significantly reduced mandibular length and alveolar height (p < 0.01). The increase in mandibular length was only 30% of that found in healthy controls. Maxillary growth was less affected by BMT treatment. In the GH treated group, no significant differences were found in craniofacial growth increments compared with controls. Although exogenous GH therapy in this group of children did not induce a catch-up growth, it appears to have prevented further loss in growth potential.
Department of Orthodontics and Paediatric Dentistry, School of Dentistry, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.
G
G
Dahllöf
C M
CM
Forsberg
B
B
Borgström
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D016022:Case-Control Studies; D002508:Cephalometry; D002648:Child; D002675:Child, Preschool; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced* / Q000175:diagnosis; D013006:Growth Hormone / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008297:Male; D016555:Matched-Pair Analysis; D008445:Maxillofacial Development / Q000187:drug effects*; D012886:Skull / Q000187:drug effects / Q000254:growth & development*
D013006:Growth Hormone